Skip to main content
. Author manuscript; available in PMC: 2020 Feb 27.
Published in final edited form as: Ophthalmic Surg Lasers Imaging Retina. 2019 Jul 1;50(7):444–449. doi: 10.3928/23258160-20190703-06

TABLE 2.

Univariate and Multivariate Logistic Regression Models of Covariates of Development of Any RVO in Fellow Eye

Variables Univariate Logistic Regression Multivariate Logistic Regression
Unadjusted OR (95% CI) P Value Adjusted OR (95% CI) P Value
Age 0.986 (0.961 – 1.012) .287 0.994 (0.959 – 1.030) .727
Gender (Ref: Females) 0.705 (0.328 – 1.512) .369
Race (Ref: Caucasian) .319+
 African-American 0.408 (0.155 – 1.076) .070
 Multiracial 0 1.000
 Other 0.647 (0.213 – 1.961) .441
Smoking status 1.059 (0.384 – 2.922) .912 3.127 (0.573 – 17.046) .188
Comorbidities
 Hypertension 0.944 (0.385 – 2.316) .901 1.133 (0.376 – 3.409) .825
 Diabetes mellitus 0.604 (0.273 – 1.338) .214 0.838 (0.299 – 2.351) .737
 Open angle glaucoma 0.643(0.287 – 1.441) .284 0.740 (0.251 – 2.184) .585
Oral Medications
 Beta blockers 0.903 (0.373 – 2.189) .822
 Antiplatelet agents 1.901 (0.842 – 4.290) .122
 ACE inhibitors 1.456 (0.591 – 3.588) .414
 Anticoagulants 0.315 (0.115 – 0.867) .025 0.571 (0.123 – 2.644) .474
 Pentoxifylline 0.157 (0.043 – 0.570) .005 0.099 (0.018 – 0.550) .008
 Ischemic CRVO in initial eye 0.266 (0.115 – 0.618) .002 0.143 (0.044 – 0.466) .001

Statistically significant P values highlighted in bold (P < .05).

RVO = retinal vein occlusion; CRVO = central retinal vein occlusion; CI = confidence interval; ACE = angiotensin converting enzyme